FDA OKs Kit Used with Hemophilia Therapy  CHICAGO (Reuters) - Wyeth Pharmaceuticals said on Monday it  received U.S. regulatory approval for a kit designed to help  patients with the blood disorder hemophilia get regular  treatments more quickly and safely.